Global Tuberculosis Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Tuberculosis Market was valued at $4.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.8% CAGR, to an estimated market size of $5.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global tuberculosis (TB) market encompasses the diagnostics and therapeutics sectors, including the development, production, and distribution of molecular tests, culture-based systems, and imaging for detection, as well as first-line and second-line pharmaceutical treatments for active and latent infections.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Tuberculosis Market in the period 2025-30:
- Rapid adoption of molecular diagnostics and nucleic acid amplification tests (NAAT) is replacing traditional culture-based methods due to faster turnaround times.
- The rising prevalence of multidrug-resistant (MDR-TB) and rifampicin-resistant strains is driving urgent demand for advanced resistance profiling tools.
- Integration of artificial intelligence (AI) and digital microscopy into diagnostic workflows is enhancing detection accuracy and screening efficiency.
- Increased funding from public-private partnerships (PPPs) and international organizations like the WHO is accelerating TB control programs in high-burden regions.
- There is a significant shift toward point-of-care (POC) testing solutions to facilitate rapid diagnosis in resource-constrained and rural environments.
- Development of shorter treatment regimens and novel drug combinations is a primary focus for pharmaceutical R&D to improve patient compliance.
- Expansion of healthcare infrastructure in emerging economies like India and China is significantly increasing case detection and treatment initiation rates.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- Asia-Pacific
- North America
- Europe
- Rest of World
Segments
- Diagnostics
- Therapeutics